» Articles » PMID: 35322144

Effects of a Gluten Challenge in Patients with Irritable Bowel Syndrome: a Randomized Single-blind Controlled Clinical Trial

Overview
Journal Sci Rep
Specialty Science
Date 2022 Mar 24
PMID 35322144
Authors
Affiliations
Soon will be listed here.
Abstract

Non-celiac gluten sensitivity (NCGS) and irritable bowel syndrome (IBS) frequently overlap. Although, gluten-free diet (GFD) and low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) improve the IBS clinical picture, many aspects remain unclear. Therefore, we designed a study to evaluate gluten tolerance, anxiety and quality of life in a specific study population. Fifty IBS patients were asked to follow a low FODMAP strict GFD for 6 weeks and were then randomly allocated to the following groups for a further 6 weeks: (A) receiving 8 g/day of gluten for 2 weeks; gluten-tolerating subjects received 16 g/day for 2 weeks and then 32 g/day for a further 2 weeks; (B) continuing to follow a low FODMAP strict GFD; and (C) receiving a gluten-containing diet. After the first 6 weeks, symptom scores significantly improved. Pain severity, bloating and total score were significantly decreased in the GFD and in the high-gluten groups, while the satiety score significantly increased in group C. Between-group analysis revealed significant differences for pain severity (p = 0.02), pain frequency (p = 0.04) and impact on community function (p = 0.02) at the end of the study. Our findings suggest that low FODMAP strict GFD could be prescribed in IBS patients and would reduce anxiety and improve the quality of life.

Citing Articles

Non-Celiac Gluten/Wheat Sensitivity-State of the Art: A Five-Year Narrative Review.

Manza F, Lungaro L, Costanzini A, Caputo F, Carroccio A, Mansueto P Nutrients. 2025; 17(2).

PMID: 39861350 PMC: 11767908. DOI: 10.3390/nu17020220.


Efficacy of Dietary Interventions for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.

Haghbin H, Hasan F, Gangwani M, Zakirkhodjaev N, Lee-Smith W, Beran A J Clin Med. 2025; 13(24.

PMID: 39768453 PMC: 11728101. DOI: 10.3390/jcm13247531.


Efficacy and Safety of a Low-FODMAP Diet in Combination with a Gluten-Free Diet for Adult Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.

Zhang J, Yu P, Xu Y, Lu X, Xu Y, Hang J Dig Dis Sci. 2024; 69(11):4124-4132.

PMID: 39407084 DOI: 10.1007/s10620-024-08671-8.


The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome.

Ionescu V, Gheorghe G, Georgescu T, Bacalbasa N, Gheorghe F, Diaconu C J Clin Med. 2024; 13(17).

PMID: 39274340 PMC: 11395839. DOI: 10.3390/jcm13175124.


The Role of Diet in the Management of Irritable Bowel Syndrome: A Comprehensive Review.

Jayasinghe M, Karunanayake V, Mohtashim A, Caldera D, Mendis P, Prathiraja O Cureus. 2024; 16(2):e54244.

PMID: 38496157 PMC: 10944297. DOI: 10.7759/cureus.54244.


References
1.
Barone M, Gemello E, Viggiani M, Cristofori F, Renna C, Iannone A . Evaluation of Non-Celiac Gluten Sensitivity in Patients with Previous Diagnosis of Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial. Nutrients. 2020; 12(3). PMC: 7146412. DOI: 10.3390/nu12030705. View

2.
Samasca G, Sur G, Lupan I, Deleanu D . Gluten-free diet and quality of life in celiac disease. Gastroenterol Hepatol Bed Bench. 2014; 7(3):139-43. PMC: 4129563. View

3.
Hauser W, Janke K, Klump B, Gregor M, Hinz A . Anxiety and depression in adult patients with celiac disease on a gluten-free diet. World J Gastroenterol. 2010; 16(22):2780-7. PMC: 2883134. DOI: 10.3748/wjg.v16.i22.2780. View

4.
Fasano A, Sapone A, Zevallos V, Schuppan D . Nonceliac gluten sensitivity. Gastroenterology. 2015; 148(6):1195-204. DOI: 10.1053/j.gastro.2014.12.049. View

5.
Hou X, Chen S, Zhang Y, Sha W, Yu X, Elsawah H . Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective.... Clin Drug Investig. 2014; 34(11):783-93. PMC: 4210642. DOI: 10.1007/s40261-014-0233-y. View